Journal Home
Search for

Volume 89, Issue 10, Pages 1880-1886 (October 2008)


View previous. 9 of 234 View next.

Do Secondary Conditions Explain the Relationship Between Depression and Health Care Cost in Women With Physical Disabilities?

Robert O. Morgan, PhDaCorresponding Author Informationemail address, Margaret M. Byrne, PhDe, Rosemary B. Hughes, PhDf, Nancy J. Petersen, PhDbc, Heather B. Taylor, PhDg, Susan Robinson-Whelen, PhDd, Jennifer C. Hasche, MScbc, Margaret A. Nosek, PhDd

Abstract 

Morgan RO, Byrne MM, Hughes RB, Petersen NJ, Taylor HB, Robinson-Whelen S, Hasche JC, Nosek MA. Do secondary conditions explain the relationship between depression and health care cost in women with physical disabilities?

Objective

To examine the influence of depression on health care utilization and costs among women with disabilities and to determine whether the severity of other secondary health conditions affects this association.

Design

A time series of 7 interviews over a 1-year period.

Setting

Large, southern metropolitan area.

Participants

Community-dwelling women (N=349) with a self-identified diagnosis of a physical disability.

Interventions

Not applicable.

Main Outcome Measures

Primary disability, secondary health conditions (Health Conditions Checklist), depressive symptoms (Beck Depression Inventory–Second Edition), and health care utilization (based on the Health and Social Service Utilization Questionnaire and the Stanford Health Assessment Questionnaire). We estimated health care costs using standardized criteria and published average costs.

Results

Outpatient and emergency department health care utilization and overall costs were higher in women with depressive symptoms and increased with the frequency and severity of the symptoms. Depressive symptoms were highly correlated with the severity of secondary health conditions. Adjusting for demographics and primary disability, both the presence and severity of depressive symptoms were associated with significantly higher health care costs. However, secondary health condition severity explained the association between depressive symptoms and cost; it also substantially increased the variance in cost that was explained by the multivariate models.

Conclusions

Secondary health conditions are significantly associated with depressive symptoms and higher health care costs, with secondary health conditions accounting for the association between depressive symptoms and costs. This association suggests that effective management of secondary health conditions may help reduce both depressive symptomatology and health care costs.

Article Outline

Abstract

Methods

Sample and Procedures

Initial interview

Bimonthly interviews

Missing visits and data aggregation

Assignment of costs

Depressive symptomatology

Other secondary health conditions

Data Analysis

Descriptive analyses

Analysis of health care utilization and costs

Results

Depressive Symptoms, Disability, and Other Secondary Health Conditions

Utilization of Medical Care

Direct Medical Care Costs

Discussion

Study Limitations

Conclusions

Acknowledgment

References

Copyright

PEOPLE LIVING WITH physical disabilities may use more types of health care providers and health care facilities than people without disabilities.1 Secondary conditions, defined as conditions that are related to or occur after the onset of a primary disability that further reduce health and independence,2, 3 may also increase health care utilization. Coyle and Santiago4 found an average of 12 secondary conditions over a 12-month period in a sample of 170 women with disabilities, with 60% of the women reporting seeing a health care provider 3 or more times during the prior 6 months; Nosek et al5 found an average of almost 15 secondary conditions, with more than 75% of the women reporting 10 or more secondary conditions.

Depression is a secondary condition that has been linked to increased utilization of health services,6, 7, 8, 9 increased costs associated with the management of other medical conditions,9, 10, 11 and substantial direct and indirect economic costs in the general population.12, 13, 14 Little research, however, has examined the relation of depression to health care use specifically in persons with disabilities, who already have high levels of health care use and who are likely experiencing a number of significant concurrent secondary medical conditions.4, 5 One study of persons with multiple sclerosis10 found that those with major depressive disorder did not have higher medical costs, more hospital admissions, or more visits to health care providers than did those without a depressive disorder. However, among people with new chronic conditions, psychosocial adjustment, which may be related to or manifested as depression, has been broadly associated with health service use.15

In this study, we tested the association of depression with health care utilization and costs in a sample of women with a variety of physical disabilities. Our hypothesis was that health care costs are higher in women with physical disabilities who report (1) depressive symptomatology and (2) the presence of additional secondary health conditions. It is unclear from prior work how depressive symptomatology and other secondary health conditions might interact to affect health care utilization and costs in this population. Consequently, an additional objective of this study was to investigate whether other secondary health conditions impact the expected effect of depressive symptomatology on health care utilization and costs.

Methods 

return to Article Outline

Sample and Procedures 

We recruited an initial sample of 443 study participants through private and public health clinics, community venues such as disability-related organizations, and a database maintained by the Baylor College of Medicine Center for Research on Women with Disabilities. The women were informed that the study sought to examine disability-related characteristics, health conditions, and health care utilization among women with physical disabilities. The study comprised seven 30-minute interviews over the course of 1 year, including an initial in-person enrollment interview and 6 bimonthly phone interviews.

Participants were English- and Spanish-speaking women who were at least 18 years of age and who self-identified as having a physical disability or health condition that limited 1 or more major life activities. We excluded women from the study who: (1) were disabled for less than 1 year; (2) reported suicidal intentions; (3) were currently abusing alcohol or other drugs; (4) had no telephone number where they could be reached; (5) were currently participating in another research study at Baylor College of Medicine Center for Research on Women with Disabilities; or (6) did not live in the Houston-Galveston area or were planning to move from the area within the next 12 months.

Initial interview 

The enrollment interview included questions about basic demographic information, current disabilities, and health status. Information was gathered about disability including disability type, age at onset, and duration. To identify disabilities, participants chose from a list of 16 physically disabling conditions plus an open-ended “other condition” category. If participants endorsed more than 1 of these conditions, they were asked to indicate which one was the most limiting; this condition was considered their primary disability.15 Participants also completed the BDI-II16 and HCC.5, 17, 18 The HCC includes 42 secondary and chronic health conditions and constitutes an adaptation of the Secondary Conditions Screening Instrument.17 Like the study protocol used by Nosek et al,5 we excluded conditions that resulted from, or reflected participants' interaction with, their environment, such as difficulties with access and equipment injuries. For our study purposes, we added female-specific conditions including yeast infection, vaginal infection, and menstrual problems.

Bimonthly interviews 

During each of the 6 bimonthly interviews, participants completed the BDI-II, HCC, and a health care utilization questionnaire developed for this study and based on the Health and Social Service Utilization Questionnaire19 and the Stanford Health Assessment Questionnaire.20 Our questionnaire collected information on inpatient, emergency department, and outpatient utilization during the past 2 months. Information on inpatient utilization included length of stay, primary and secondary diagnoses, primary reason for visit (ie, primary disability, depression, or other), and placement at discharge (eg, discharged to home). Information on emergency department visits included primary reason for visit. Information on outpatient visits included primary reason for visit and type of physician seen (ie, primary care physician, specialist, mental health care provider, other).

Missing visits and data aggregation 

We assessed health care use every 2 months to reduce recall bias on the part of the study participants, and we aggregated reported use for each person across the 1-year follow-up period. We excluded from analyses all participants who missed more than 1 interview. For women who missed 1 interview, we imputed the missing values for outpatient visits using the mean number of outpatient visits reported during their other 5 interviews. Emergency department visits and inpatient stays were much less frequent; therefore, we used a regression-based method to impute emergency department visits and inpatient stays for participants who missed 1 interview. To impute inpatient visits, we regressed the number of inpatient stays onto the total number of outpatient visits during the entire study period using data from women who had not missed any interviews. Using the intercept and outpatient visit coefficients from this regression, we then calculated the expected number of inpatient stays for the missing interview period. We used the same procedure to estimate emergency department visits during the lost 2-month interview period.

Assignment of costs 

We measured direct costs by assessing the patient's use of health care services.21, 22 We identified all medical resource use as described above and then identified a dollar cost for these units based on Medicare reimbursements. For inpatient stays, a certified medical coder assigned a probable International Classification of Diseases–Ninth Revision–Clinical Modification diagnosis code based on the participant's reported primary reason for hospitalization, and we computed direct costs according to the average national price for the appropriate diagnosis related group. Outpatient costs were assigned by our medical coder using the Berenson-Eggers type of service coding system (http://www.cms.hhs.gov/hcpcsreleasecodesets/20_betos.asp). The Berenson-Eggers type of service codes consist of readily understood clinical categories that permit objective assignment. Outpatient costs were determined using the most recent cost data available (2002) at the time of the study for each Berenson-Eggers type of service code. The investigators, study staff, and the study's medical coder jointly reviewed all inpatient and outpatient coding. Total costs were computed as the sum of inpatient and outpatient costs.

Depressive symptomatology 

We categorized participants as ever depressed if they scored 17 or higher on the BDI-II16 at any of the interviews. We further categorized participants into 1 of 4 categories based on the number of interviews in which their BDI-II scores were 17 or higher: never depressed (BDI score <17 at all interviews), depressed some of the time (BDI score ≥17 at 1–3 interviews), depressed most of the time (BDI score ≥17 at 4–6 interviews), or always depressed (BDI score ≥17 at all interviews). Participants who were missing 1 or more BDI scores were categorized based on the percentage of times their BDI scores were 17 or higher. Finally, we calculated an average of all recorded BDI scores over the full year for each participant.

Other secondary health conditions 

Respondents were asked on the HCC to rate the severity of 42 secondary and chronic health conditions on a scale of 0 to 4 (0, not a problem in the previous 2 months; 1, mild or infrequent problem; 2, moderate or occasional problem; 3, significant or chronic problem; 4, never had this condition). We classified participants as endorsing a secondary condition if they responded with 1, 2, or 3. Participants responding with 0 or 4 were considered to not have that secondary condition. The interference ratings for each secondary condition endorsed by the participant were summed to assess the cumulative impact.5 Although depression is included on the HCC, we specifically excluded it from the HCC severity score. As a result, the HCC severity scale could range from 0 to 123, with higher scores indicating greater interference from secondary conditions. For the purposes of these analyses, HCC severity scores were averaged across all interviews.

Data Analysis 

Descriptive analyses 

We compared demographic and disability characteristics of participants who were included in these analyses with participants who were excluded (>1 missed visit). In addition, we compared the demographic characteristics of participants with complete data with participants who missed 1 interview. We estimated the occurrence of depressive symptoms during the study period across the entire sample and within specific disability groups.

Analysis of health care utilization and costs 

We compared the average numbers of outpatient visits, emergency department visits, and inpatient stays between ever depressed and never depressed groups of women. Ever depressed women were further subcategorized by the frequency (ie, depressed some of the time, most of the time, all of the time) and the severity (average BDI-II score) of their depression.

We then ran 4 sets of linear regression models on our aggregated total direct cost measure to determine which factors affected participant costs. For the first set, the primary explanatory variables were dummy variables for primary disability category and presence of depressive symptoms at any point during the study (ever depressed vs never depressed). We included age, race, income level (categorized as: ≤$15,000; >$15,000; not reported), education, and length of disability as covariates. In the second set of regression models, we replaced the dichotomous depression variable with categorical variables for the 4 frequency categories of depression. In the third set of regressions, we used the year-long average BDI score. Within each of these 3 sets, we ran the regression model with and without the average HCC severity score (omitting depression) as a predictor to test whether the cumulative severity of secondary health conditions affected any of the relationships observed between depressive symptomatology and total cost of care. We then ran a final regression model to test the association of the average HCC severity score with total cost in the absence of our measures of depressive symptoms.

Results 

return to Article Outline

Compared with included participants (N=349), women who were excluded for missing more than 1 interview (n=94) had lower personal and household incomes, were less likely to report being ever treated for depression, and had higher BDI scores (all P<.05) (table 1). Of the 349 women included in these analyses, 290 (83%) had complete interview data, and 59 (17%) were missing data for 1 interview. There were no demographic differences between participants with complete data and those with 1 missing interview.

Table 1.

Population Characteristics at Baseline

VariableAnalysis Sample (N=349)Excluded Participants (n=94)
Mean ± SD or % (N)RangeMean ± SD or % (N)Range
Age (y)53.1±11.121–8352.5±12.218–78
Race
White35.8(125) 34.0(32)
Black33.5(117) 35.1(33)
Hispanic23.2(81) 25.5(24)
Other7.5(26) 5.3(5)
Spanish language11.5(40) 12.8(12)
Primary disability
SCI11.8(41) 12.8(12)
Polio6.1(21) 4.3(4)
JCTD47.6(166) 52.1(49)
Stroke9.7(34) 11.7(11)
MS10.9(38) 4.3(4)
Other14.0(49) 14.9(14)
Having disability (mo)156.4±167.912–864126.1±142.212–730
Ever treated for depression (%)53.0(185) 41.5(39)
Income ($)
Personal10,387±11,9690–85,0006857±94890–75,000
Household23,146±28,8381620–175,00013,995±25,4000–180,000
Education
Less than high school11.8(41) 17.0(16)
GED/high school grad28.1(98) 28.7(27)
Some college/tech school42.4(148) 41.5(39)
College degree or more17.8(62) 12.8(12)
Depression
Average BDI score14.7±11.10–5617.5±12.90–58
BDI score ≥1736.7(128) 48.9(46)
HCC severity score26.1±13.32–6525.9±13.50–70

Abbreviations: GED, General Equivalency Diploma; JCTD, joint and connective tissue disease; MS, multiple sclerosis; SCI, spinal cord injury.

Women disabled due to joint and connective tissue disease were the most numerous in our analysis sample (see table 1). Of the 349 women, 166 (47.6%) indicated a range of subtypes of joint and connective tissue disease, with 72 (43.4%) having rheumatoid arthritis, 33 (19.9%) with osteoarthritis, 10 (6.0%) with fibromyalgia, 5 (3.0%) with lupus, 2 (1.2%) with scleroderma, and 7 (4.2%) indicating other. In addition, 34 (20.5%) women indicated multiple subtypes of joint and connective tissue disease, and 3 (1.8%) did not indicate a subtype.

Depressive Symptoms, Disability, and Other Secondary Health Conditions 

Slightly more than half of the 349 women, 201 (57.6%) were depressed at some point (ever depressed), and 26 (7.5%) were depressed throughout the duration of the study (always depressed) (table 2). Women disabled due to joint and connective tissue disease, a stroke, or multiple sclerosis were the most likely to have had depressive symptoms (χ12=13.72, P≤.001), with more than 60% of the women in each of those groups classified as depressed at some point during the study. Severity of depressive symptoms, as represented by the average BDI score over the duration of the study, was highly correlated with the average severity score for other secondary health conditions (r=.58, P≤.001).

Table 2.

Presence and Frequency of Depression Across All Participants and by Primary Disability (N=349)

VariableNever DepressedEver DepressedDepressed Some of the TimeDepressed Most of the TimeAlways Depressed
All participants148(42.4)201(57.6)98(28.1)77(22.1)26(7.5)
SCI21(51.2)20(48.4)10(24.4)10(24.4)0(0.0)
Polio14(66.7)7(33.3)5(23.8)2(9.5)0(0.0)
JCTD58(34.9)108(65.1)48(28.9)41(24.7)19(11.5)
Stroke13(38.2)21(61.8)9(34.2)8(23.5)4(11.8)
MS14(36.8)24(63.2)13(34.2)8(21.1)3(7.9)
Other28(57.1)21(42.9)13(26.5)8(16.3)0(0.0)

NOTE. Values are n (%).

Abbreviations: JCTD, joint and connective tissue disease; MS, multiple sclerosis; SCI, spinal cord injury.

Participants who were “ever” depressed were also subdivided into these 3 depression frequency categories.

Utilization of Medical Care 

Our unadjusted analyses (Kruskal-Wallis rank order analysis of variance) showed women who were classified as ever depressed used some types of health care more frequently than women who were classified as never depressed (table 3). This observation was especially true for outpatient physician use. Women classified as ever depressed reported significantly more outpatient visits during the year than women classified as never depressed (χ12=14.26, P≤.001). Furthermore, rates of outpatient physician use over the study period increased steadily as the frequency of depressive symptoms increased (χ32=20.74, P≤.001) (see table 3). Women who were classified as always depressed reported almost twice as many outpatient visits a year as women classified as never depressed (20.32±15.13 vs 10.57±8.23) (see table 3).

Table 3.

Summary of 12-Month Utilization by Depression Status (N=349)

UtilizationNever DepressedEver DepressedDepressed Some of the TimeDepressed Most of the TimeAlways Depressed
All outpatient visits10.57±8.2315.09±11.9812.86±9.7416.15±12.8220.32±15.13
Reason for visit
Primary disability5.56±4.997.70±8.076.08±4.769.55±10.898.36±7.17
Depression0.49±2.722.01±4.991.51±4.041.88±4.574.32±8.13
Other4.59±4.315.58±5.275.47±5.044.77±4.568.35±7.11
Provider seen
Primary care provider4.13±3.665.22±4.224.71±3.295.45±4.966.45±4.80
Specialist (not PCP)4.84±5.236.19±7.835.04±5.567.23±9.717.45±8.56
Psychologist/mental health0.52±2.712.05±4.951.54±3.841.84±4.464.58±8.40
Other1.00±1.621.46±2.460.49±2.141.40±2.431.79±3.01
All ED visits0.61±0.960.90±1.230.74±1.140.88±1.161.58±1.55
Reason for visit
Primary disability0.24±0.660.25±0.570.19±0.440.19±0.480.63±0.98
Depression0.00±0.000.02±0.140.02±0.140.00±0.000.08±0.27
Other0.42±0.710.66±1.070.55±0.940.70±1.050.96±1.47
All inpatient stays0.60±0.950.75±1.300.60±0.920.76±0.991.31±2.60
Total no. of days in hospital3.14±6.893.46±9.332.24±4.643.60±10.077.66±16.75
Reason for hospitalization
Primary disability0.25±0.690.31±0.940.19±0.610.33±0.690.67±2.00
Depression0.00±0.000.04±0.230.51±0.300.13±0.110.04±0.20
Other0.35±0.630.42±0.720.37±0.690.42±0.670.60±0.91

NOTE. Values are mean ± SD.

Abbreviations: ED, emergency department; PCP, primary care physician.

Women classified as ever depressed also had higher rates of emergency department use than women classified as never depressed (χ12=6.14, P≤.01). The frequency of emergency department visits also varied significantly by frequency of depressive symptoms (χ32=17.75, P≤.001) (see table 3), with women classified as “always depressed” having the highest rate of emergency department use. Rates of inpatient admission did not significantly differ among women with and without depressive symptoms.

Direct Medical Care Costs 

The overall mean annual total direct medical care cost per participant ± SD ($) was $4471±$7338. As anticipated, the cost distributions were highly skewed. The overall median cost was $1699 (interquartile range, $5311), substantially lower than the mean total cost. Inpatient costs accounted for approximately 73% ($3256±$6878) of the mean total costs, with 11% ($490±$416) of the mean total costs attributable to outpatient physician costs and 1% ($54±$79) to emergency department costs. An additional 8% ($326±$382) was attributable to procedure costs, and 7% ($311±$607) was for the use of alternative providers.

Our preliminary (unadjusted) analysis indicated that participants who were classified as ever depressed had significantly higher total direct medical care costs ($5045±$8797 vs $3692±$4961, for ever-depressed vs never-depressed women, respectively; Kruskal-Wallis rank order analysis of variance, χ12=6.22, P≤.01). Total medical care costs increased with the frequency of depressive symptoms ($3692±$4961, $3688±$4543, $5062±$6795, $10,106±$19,100, for women who were classified as never depressed, depressed some of the time, depressed most of the time, and always depressed, respectively; Kruskal-Wallis rank order analysis of variance, χ32=12.58, P<.01).

Because the distribution of medical care costs was severely skewed, we log-transformed the total cost variable prior to conducting our linear regressions. Our examination of model results indicated that transforming total costs achieved a close adherence to necessary model assumptions. As described above, we defined the depression variable differently in the first 3 sets of models: the presence of depressive symptoms (ie, ever vs never depressed), frequency of depressive symptoms (ie, depressed never, some, most, all of the study period), and severity of depressive symptoms (average BDI-II score across the study period). In all other respects, the models used identical parameters (table 4).

Table 4.

Depression, Severity of Secondary Medical Conditions, and Log-Transformed Total Direct Medical Care Costs (N=349)

VariabledfModel Set 1 Ever DepressedModel Set 2 Frequency of DepressionModel Set 3 Severity of DepressionModel Set 4 HCC Severity
Without HCCWith HCCWithout HCCWith HCCWithout HCCWith HCCOmitting Depression
Parameter (SE)Parameter (SE)Parameter (SE)Parameter (SE)Parameter (SE)Parameter (SE)Parameter (SE)
Intercept17.18(0.58)§5.87(0.53)§6.55(0.56)§5.87(0.54)§6.06(0.57)§5.84(0.54)§5.88(0.53)§
Age10.02(0.01)0.01(0.01)0.02(0.01)0.01(0.01)0.02(0.01)0.01(0.01).01(0.01)
Race (ref=white)
Black10.06(0.21)−0.00(0.20)0.09(0.21)0.01(0.20)0.12(0.21)0.01(0.20)0.00(0.20)
Hispanic10.27(0.26)0.17(0.24)0.29(0.26)0.18(0.25)0.32(0.26)0.18(0.25)0.17(0.24)
Other race1−0.71(0.33)−0.86(0.31)−0.69(0.32)−0.86(0.31)−0.71(0.32)−0.87(0.31)−0.87(0.30)
Income ($) (ref=NR)
≤15k10.08(0.19)−0.05(0.18)0.02(0.19)−0.06(0.18)0.01(0.19)−0.06(0.18)−0.05(0.18)
>15k10.19(0.22)0.23(0.20)0.18(0.22)0.22(0.20)0.16(0.21)0.23(0.20)0.23(0.20)
Education (ref=college)
Less than HS1−0.73(0.36)−0.44(0.34)−0.74(0.36)−0.46(0.34)−0.73(0.36)−0.46(0.34)−0.44(0.34)
GED or HS10.05(0.27)0.12(0.25)−0.02(0.27)0.09(0.25)−0.06(0.27)0.10(0.25)0.12(0.25)
Some college1−0.26(0.23)−0.19(0.22)−0.28(0.23)−0.21(0.22)−0.32(0.23)−0.21(0.22)−0.20(0.22)
Disability (ref=other)
SCI10.39(0.33)0.26(0.30)0.39(0.32)0.27(0.31)0.42(0.32)0.27(0.30)0.26(0.30)
Polio1−0.06(0.43)−0.42(0.40)−0.07(0.43)−0.42(0.40)−0.16(0.42)−0.42(0.40)−0.42(0.40)
JCTD1−0.13(0.25)−0.38(0.24)−0.21(0.25)−0.39(0.24)−0.26(0.25)−0.39(0.24)−0.39(0.23)
Stroke10.12(0.34)0.06(0.32)0.06(0.34)0.05(0.32)0.02(0.34)0.04(0.32)0.06(0.32)
MS11.06(0.34)1.12(0.31)§1.04(0.33)1.12(0.32)§1.02(0.33)1.11(0.32)§1.12(0.31)§
Duration of disability1−0.00(0.00)−0.00(0.00)−0.00(0.00)−0.00(0.00)−0.00(0.00)−0.00(0.00)−0.00(0.00)
Average HCC severity1NI0.06(0.01)§NI0.05(0.10)§NI0.05(0.01)§0.06(0.01)§
Ever depressed (vs never)10.54(0.17)−0.02(0.18)NININININI
Depressed (ref=never)
Some1NINI0.29(0.20)−0.09(0.19)NININI
Most1NINI0.73(0.22)§0.09(0.23)NININI
Always1NINI1.16(0.33)§0.09(0.36)NININI
Average depression1NINININI0.04(0.01)§0.00(0.01)NI
R2 0.120.230.140.230.140.230.23
Adjusted R2 0.070.190.090.190.100.190.20

Abbreviations: GED, General Equivalency Diploma; HS, high school; JCTD, joint and connective tissue disease; MS, multiple sclerosis; NI, not included in model; NR, not reported; ref, reference; SCI, spinal cord injury.

All effects adjusted for the other parameters in the model.

|t|<.1.

|t|<.05.

§

|t|<.001.

Controlling for demographic characteristics and primary disability, the presence of depressive symptoms was significantly related to higher log-transformed total medical care costs, with greater frequency and greater severity both related to higher costs. However, in each case, controlling for the average HCC severity score completely attenuated the relation between depressive symptoms and medical care costs. The average HCC severity score remained highly significant. Furthermore, including the average HCC severity score essentially doubled the adjusted R2 of each model. In contrast, comparing the first 3 sets of models to our fourth model, including our measures of depressive symptomatology in the models had virtually no impact on the association of the average HCC severity score with the log-transformed total cost. There were no statistically significant interactions between our measures of depression and the average HCC severity score in their prediction of the log-transformed total cost.

Discussion 

return to Article Outline

Consistent with previous findings, the women in our study had multiple medical conditions and a high prevalence of depression in addition to their primary physical disabilities. Our research suggests a significant association among depression, other secondary health conditions, and medical care costs, supporting both of our hypotheses. More specifically, we found that, after adjusting for individual characteristics including age, race, income level, education, and length of disability, both depressive symptomatology and the presence of other secondary health conditions (the HCC severity score) were separately associated with higher medical care costs. Further, when these variables were included in the same model, variance in the HCC severity scores completely accounted for the relation between depressive symptomatology and medical care costs.

Although we omitted depression from the calculation of our HCC severity score, depression has been linked to heightened awareness of physical symptoms.23 Consequently, our measure of the severity of other health conditions may, in part, reflect the influence of depression on participants' perceptions of their symptoms. However, the association between the HCC severity score and total cost was unaffected by the inclusion of our measures of depressive symptoms in the models. In contrast, the addition of the HCC severity score in our models eliminated any independent association between depressive symptoms and costs, and doubled the amount of variance accounted for in each of the first 3 sets of models. Based on our findings, we hypothesize that the presence and severity of other secondary health conditions is the primary factor linking higher medical care costs and increased depressive symptomatology in this population.

Study Limitations 

Our analyses of health care utilization and cost were conducted on the 349 study participants for whom we had accumulated at least 10 months of interview data. The 94 participants we excluded tended to have lower incomes and were more depressed than women for whom we had more complete data. Consequently, our analyses may have underestimated the relation between depression and health care costs among the participants in our study, limiting our ability to disentangle the effects of depressive symptomatology from those of the other secondary health conditions. Further, we obtained all of our utilization data through interviews. Although we took pains to standardize the interview process and to limit the span of the recall period, we could not directly validate the information provided by our participants.

Our analyses examined aggregate use and cost across our 1-year follow-up period. As such, we did not examine specific patterns of utilization within that timeframe. Further work should explore the longitudinal relationship between secondary health conditions, depression, and specific types of health care use (eg, use of outpatient care, timing of inpatient admissions). Our measure of medical care cost also did not include the costs of prescription medications. Further work is necessary to determine whether the findings we report here extend to medication use.

Conclusions 

return to Article Outline

We strongly encourage the development and widespread implementation of effective and culturally relevant interventions to prevent and manage depression and other secondary conditions in women with disabilities. Previous research has linked depression to higher costs of health care in general outpatient populations13, 14 and among chronically ill patients.8, 11, 12 Other research has demonstrated that secondary and other health conditions are associated with greater health care costs among people who are depressed.24, 25, 26 These findings are all supported in the work presented here. However, prior work has not specifically examined how depression and secondary health conditions jointly influence health care utilization and costs among people, specifically women, with disabilities. The health and health care needs of women with physical disabilities are great,4, 5 with the vast majority of women reporting multiple medical conditions. In this study, more than half of our sample reported significant depressive symptomatology at some point during the year. Although more research is needed to deepen our understanding of the health and health care needs of women with physical disabilities, our findings suggest that effective management of secondary and other health conditions may also help reduce both depressive symptoms and health care utilization.

Acknowledgments 

return to Article Outline

We thank Beth Mastel-Smith, PhD, for her assistance in conducting this study; Andrea Bradford, PhD, for her suggestions on revising the manuscript draft; and Chris Murphy, BFA, Donna Espadas, BS, and Karyn Harvey, BA, for their assistance in preparing the manuscript and tables.

References 

return to Article Outline

1. 1Nosek MA, Howland CA, Rintala DH, Young ME, Chanpong GF. National study of women with physical disabilities: final report. Sex Disabil. 2001;19:5–39.

2. 2Brandt E, Pope A. Enabling America: assessing rehabilitation science and engineering. Washington (DC): Institute of Medicine, National Academy of Science; 1997;.

3. 3Turk M. Appendix J: secondary conditions and disability. In:  Field MJ,  Jette A,  Martin L editor. Workshop on disability in America: a new look (Summary and background papers. Based on a Workshop of the Committee on Disability in America: a new look, board on health sciences policy). Washington (DC): Natl Acad Pr; 2006;p. 185–193.

4. 4Coyle CP, Santiago MC. Healthcare utilization among women with physical disabilities. Medscape Womens Health. 2002;7:2. MEDLINE

5. 5Nosek MA, Hughes RB, Petersen NJ, et al. Secondary conditions in a community-based sample of women with physical disabilities over a 1-year period. Arch Phys Med Rehabil. 2006;87:320–327. Abstract | Full Text | Full-Text PDF (118 KB) | CrossRef

6. 6Cassem EH. Depressive disorders in the medically ill (An overview). Psychosomatics. 1995;36:S2–S10. MEDLINE

7. 7Druss BG, Rohrbaugh RM, Rosenheck RA. Depressive symptoms and health costs in older medical patients. Am J Psychiatry. 1999;156:477–479.

8. 8Himelhoch S, Weller WE, Wu AW, Anderson GF, Cooper LA. Chronic medical illness, depression, and use of acute medical services among Medicare beneficiaries. Med Care. 2004;42:512–521. MEDLINE | CrossRef

9. 9Johnson J, Weissman MM, Klerman GL. Service utilization and social morbidity associated with depressive symptoms in the community. JAMA. 1992;267:1478–1483. MEDLINE

10. 10Patton SB, Jacobs P, Petcu R, Reimer MA, Metz LM. Major depressive disorder and health care costs in multiple sclerosis. Int J Psychiatry Med. 2002;32:167–178. MEDLINE | CrossRef

11. 11Robinson RL, Birnbaum HG, Morley MA, Sisitsky T, Greenberg PE, Wolfe F. Depression and fibromyalgia: treatment and cost when diagnosed separately or concurrently. J Rheumatol. 2004;31:1621–1629.

12. 12Katon WJ, Lin E, Russo J, Unutzer J. Increased medical costs of a population-based sample of depressed elderly patients. Arch Gen Psychiatry. 2003;60:897–903. CrossRef

13. 13Rowan PJ, Davidson K, Campbell JA, Dobrez DG, MacLean DR. Depressive symptoms predict medical care utilization in a population-based sample. Psychol Med. 2002;32:903–908. MEDLINE

14. 14Simon G, Ormel J, VonKorff M, Barlow W. Health care costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry. 1995;152:352–357.

15. 15Browne GB, Arpin K, Corey P, Fitch M, Gafni A. Individual correlates of health service utilization and the cost of poor adjustment to chronic illness. Med Care. 1990;28:43–58. MEDLINE | CrossRef

16. 16Beck AT, Steer RA, Brown GK. Manual for Beck Depression Inventory-II. 11th ed.. San Antonio: Psychological Corp; 1996;.

17. 17Ravesloot C, Seekins T, Walsh J. A structural analysis of secondary conditions experienced by people with physical disabilities. Rehabil Psychol. 1997;42:3–19.

18. 18Seekins T, Smith N, McCleary T, Clay J, Walsh J. Secondary disability prevention: involving consumers in the development of a public health surveillance instrument. J Disabil Policy Stud. 1990;1:21–39.

19. 19Browne G, Gafni A, Roberts J, Goldsmith A, Jamieson E. Approach to the measurement of costs (expenditures) when evaluating health and social programmes. Hamilton: McMaster Univ; 1995;95-11.

20. 20Ramey DR, Raynauld JP, Fries JF. The health assessment questionnaire 1992: status and review. Arthritis Care Res. 1992;5:119–129. MEDLINE

21. 21Clarke AE, Zowall H, Levinton C, et al. Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12 year study. J Rheumatol. 1997;24:1051–1060.

22. 22Dranone D. Measuring costs. In:  Dranove D,  Sloan FA editor. Valuing health care costs: costs, benefits and effectiveness of pharmaceuticals and other medical technologies. Cambridge: Cambridge Univ Pr; 1996;p. 61–75.

23. 23Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry. 2003;54:216–226. Abstract | Full Text | Full-Text PDF (124 KB) | CrossRef

24. 24Bao Y, Sturm R, Croghan TW. A national study of the effect of chronic pain on the use of health care by depressed persons. Psychiatr Serv. 2003;54:693–697. MEDLINE | CrossRef

25. 25Bernatsky S, Dobkin PL, De CM, Penrod JR. Co-morbidity and physician use in fibromyalgia. Swiss Med Wkly. 2005;135:76–81. MEDLINE

26. 26Penrod JR, Bernatsky S, Adam V, Baron M, Dayan N, Dobkin PL. Health services costs and their determinants in women with fibromyalgia. J Rheumatol. 2004;31:1391–1398.

a Division of Management, Policy, and Community Health, University of Texas School of Public Health, Houston, TX

b Houston Center for Quality of Care and Utilization Studies, Veterans Health Affairs, Houston, TX

c Department of Medicine, Baylor College of Medicine, Houston, TX

d Center for Research on Women with Disabilities, Department of Physical Medicine and Rehabilitation, Baylor College of Medicine, Houston, TX

e Department of Epidemiology and Public Health, University of Miami School of Medicine, Miami, FL

f University of Montana Rural Institute on Disabilities, Missoula, MT

g University of Texas Health Science Center, Houston, TX

Corresponding Author InformationReprint requests to Robert O. Morgan, PhD, Division of Management, Policy, and Community Health, University of Texas School of Public Health, 1200 Herman Pressler, Room E-343, Houston, TX 77030

 Supported by the Centers for Disease Control and Prevention (grant no. RO4/CCR618805), the Department of Veterans Affairs Health Services Research and Development (HSR&D) Service through the Houston Center for Quality of Care and Utilization Studies (grant no. HFP 90-020), and the HSR&D's Measurement Excellence in Training and Research Information Center (grant no. RES 03-235).

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit on the authors or on any organization with which the authors are associated.

PII: S0003-9993(08)00462-0

doi:10.1016/j.apmr.2008.03.011


View previous. 9 of 234 View next.